Hilo Secures $19 Million in Series B Extension Led by Dell Family Office

Hilo Secures $19 Million in Series B Extension

Hilo, a Neuchâtel-based company specializing in clinically validated blood pressure monitoring solutions, has successfully raised $19 million in a Series B extension funding round. The funding was led by Dell Family Office, with no additional investors disclosed at this time.

Leadership and Vision

Hilo was co-founded by Josep Sola, who serves as the company's Chief Technology Officer, and Mattia Bertschi, who is a board member and Chief Operating Officer. The company is currently led by CEO Stefan Petzinger, who also sits on the board of directors. These executives have been instrumental in steering the company towards its mission of providing stress-free, round-the-clock blood pressure monitoring.

Strategic Use of Funds

While specific plans for the newly acquired funds have not been detailed, the investment is expected to support the ongoing development and expansion of Hilo's blood pressure monitoring technology. This could potentially include enhancements in product features, scaling production capabilities, or expanding market reach.

Location and Market

Operating out of Neuchâtel, Switzerland, Hilo is positioned in a growing market for health monitoring solutions, which is seeing increasing demand for reliable and user-friendly products. The company's focus on clinically validated technology aims to provide users with accurate and convenient health data.

Conclusion

With the support of Dell Family Office, Hilo is well-positioned to continue its growth trajectory in the health technology sector. The new funding will likely aid in further developing their innovative solutions, aligning with a global trend towards more personalized and accessible health monitoring tools.